Broadening Inflation Pressures Beyond Energy and Geopolitical Shocks
BP Ousts Chairman Amid Allegations of Bullying Conduct
Core Scientific Targets 15 GW Power Capacity at Muskogee Campus in Major Expansion Plan
Nasa Taps Blue Origin for First Uncrewed Lunar Mission as 20bn Moon Base Plans Move Forward
Microsoft Appoints Trusted Technology Lead to Bridge Speed and Responsibility in AI Development
Equinor Receives Analyst Upgrade Amid Tightening European Gas Market
Banco Macro SA BMA Q4 2025 Earnings Strong EPS Beat Overshadowed by Broader Market Headwinds
DPRO Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Stock Gains on Optimism Around Operational Progress
JVA Q4 2019 Earnings Coffee Holding Co Misses EPS Estimates by Wide Margin
ESS Tech Inc GWH Q1 2026 Earnings Significant EPS Miss Amidst Revenue Disconnect Stock Gains 386
ATO Q1 2026 Earnings EPS Beat Amid Natural Gas Utility Strength
NFT Limited MI Q3 2018 Earnings Massive EPS Miss Sends Stock Sharply Lower
GPAct III Acquisition Corp GPAT Holds Steady Near NAV with Modest Uptick
Helmerich Payne HP Edges Higher as Stock Holds Above Key Support
National CineMedia NCMI Holds Steady Near Support Amid Modest Decline
EW Scripps SSP Struggles Near Support as Media Sector Headwinds Persist
PEBK Holds Steady Peoples Bancorp of North Carolina Trades Near Resistance With Modest Gains
APWC Q3 1997 Earnings EPS Misses Estimates as Stock Rises Despite Headwinds
CMS Energy Corporation 5875 Junior Subordinated Notes due 2078 CMSC Q1 2026 Earnings Common Share EPS Beat Drives Modest Note Price Decline
UFPT Q1 2026 Earnings EPS Misses Estimates but Shares Edge Higher
ORKT Q0 2024 Earnings Substantial EPS Miss as Revenue Remains Undisclosed
RXO Reports Continued Surge in Truckload Spot Market During Second Quarter
Minerva Neurosciences Q1 2026 Earnings EPS Misses Street Estimates Stock Gains on Pipeline Optimism
CocaCola and Procter Gamble Two Dividend Stocks Under LongTerm Focus
NOA Q1 2026 Earnings EPS Misses Estimates But Stock Rises 225 on Resilient Operations
Travere Therapeutics TVTX Hovers Near Resistance as Slight Dip Tests Support Levels